ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 87 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $7,000 | -98.8% | 2,200 | -96.6% | 0.00% | -100.0% |
| Q1 2017 | $592,000 | +19.4% | 64,307 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $496,000 | -32.5% | 64,307 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $735,000 | -7.2% | 64,307 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $792,000 | +21.8% | 64,307 | 0.0% | 0.01% | +16.7% |
| Q1 2016 | $650,000 | -55.1% | 64,307 | 0.0% | 0.01% | -57.1% |
| Q4 2015 | $1,449,000 | +32.2% | 64,307 | -2.7% | 0.01% | +27.3% |
| Q3 2015 | $1,096,000 | -26.3% | 66,070 | 0.0% | 0.01% | -38.9% |
| Q2 2015 | $1,487,000 | +2.4% | 66,070 | +17.4% | 0.02% | +12.5% |
| Q1 2015 | $1,452,000 | +18.4% | 56,300 | 0.0% | 0.02% | +14.3% |
| Q4 2014 | $1,226,000 | – | 56,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $16,944,000 | 4.17% |
| BVF INC/IL | 1,760,489 | $16,214,000 | 2.76% |
| Iguana Healthcare Management, LLC | 490,000 | $4,513,000 | 2.23% |
| Broadfin Capital, LLC | 300,000 | $2,763,000 | 0.34% |
| TURNER INVESTMENTS LLC | 38,083 | $351,000 | 0.23% |
| Birchview Capital, LP | 34,689 | $319,000 | 0.18% |
| Piermont Capital Management Inc. | 52,195 | $481,000 | 0.12% |
| Cannell & Co. | 331,296 | $3,051,000 | 0.11% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $442,000 | 0.08% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 324,350 | $2,987,000 | 0.07% |